The notices it replaced
- Reissues: PAR-13-029 Opportunities for Collaborative Research at the NIH Clinical Center (U01)
Replaced by PAR-15-287.
Who won it before
21 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $10,319,372 in first-year total cost, median $470,524.
Most frequent study sections
- Special Emphasis Panel[ZRG1 BDCN-L (60)]5
- Special Emphasis Panel[ZAI1 BLG-M (S1)]3
- Special Emphasis Panel[ZCA1 SRLB-R (O1)]3
- Special Emphasis Panel[ZHL1 CSR-S (O1)]3
- Special Emphasis Panel[ZCA1 RPRB-M (O2)]2
Most frequent institutions
- BRIGHAM AND WOMEN'S HOSPITAL2
- CHILDREN'S RESEARCH INSTITUTE2
- BECKMAN RESEARCH INSTITUTE/CITY OF HOPE1
- CHILDREN'S HOSP OF PHILADELPHIA1
- GEORGIA INSTITUTE OF TECHNOLOGY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | The Molecular and Genetic Pathogensis of LAM1U01HL131022-01 | HENSKE, ELIZABETH P | BRIGHAM AND WOMEN'S HOSPITAL, MA | $754,946 | ZHL1 |
| 2016 | Developing a translational pipeline for NF1-mutant malignancies1U01CA202943-01 | CICHOWSKI, KAREN MWIDEMANN, BRIGITTE | BRIGHAM AND WOMEN'S HOSPITAL, MA | $578,917 | ZCA1 |
| 2016 | Underlying Mechanisms of Vascular Disease1U01HL131019-01 | BOEHM, MANFREDIRUELA-ARISPE, M. LUISA | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $524,790 | ZHL1 |
| 2016 | Developing clinical, immunologic and radiographic tools to measure the clinical effect of immunotherapy in biochemically recurrent prostate cancer1U01CA202939-01 | GULLEY, JAMES L.KANTOFF, PHILIP W | SLOAN-KETTERING INST CAN RESEARCH, NY | $470,524 | ZCA1 |
| 2016 | Microbial, immune, metabolic perturbations by antibiotics (MIME study)1U01AI122285-01 | BLASER, MARTIN J | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $423,750 | ZAI1 |
| 2015 | Choroid Plexus-Directed Gene Therapy for Alpha-Mannosidosis1U01HD079066-01A1 | WOLFE, JOHN H | CHILDREN'S HOSP OF PHILADELPHIA, PA | $656,702 | ZRG1 |
| 2015 | Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant1U01AI115714-01 | MASUR, HENRYSTOCK, PETER G | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $601,291 | ZAI1 |
| 2015 | Phase II Study of AAV9-GAA Gene Transfer in Pompe Disease1U01HL121842-01A1 | BYRNE, BARRY J | UNIVERSITY OF FLORIDA, FL | $601,129 | ZHL1 |
| 2015 | Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative U01 Grant1U01AI115711-01 | GRINSPOON, STEVEN K.HADIGAN, COLLEEN M | MASSACHUSETTS GENERAL HOSPITAL, MA | $587,655 | ZAI1 |
| 2015 | Beyond the reproductive tract: The future of Y chromosome research1U01HG007587-01A1 | MUENKE, MAXIMILIANPAGE, DAVID C. | WHITEHEAD INSTITUTE FOR BIOMEDICAL RES, MA | $487,619 | GNOM |
| 2015 | Cerebellar Structure and Function Studies in Very Early Abstinence1U01AA023674-01 | FEIN, GEORGE | NEUROBEHAVIORAL RESEARCH, INC., HI | $464,024 | ZRG1 |
| 2015 | Mucosal and Systemic Immune Responses to Influenza Virus1U01AI115715-01 | GREENBERG, HARRY BERNARD | PALO ALTO VETERANS INSTIT FOR RESEARCH, CA | $427,852 | ZAI1 |
| 2015 | PSMA Directed Imaging of Prostate Cancer Focus on Androgen Receptor Dynamics1U01CA183031-01A1 | DEWEESE, THEODORE LPOMPER, MARTIN G | JOHNS HOPKINS UNIVERSITY, MD | $410,209 | ZCA1 |
| 2015 | Antiretroviral Therapy in Aicardi Goutieres Syndrome1U01HD082806-01 | GAHL, WILLIAM ALLENVANDERVER, ADELINE LUCIE | CHILDREN'S RESEARCH INSTITUTE, DC | $288,019 | ZRG1 |
| 2015 | Single chain urokinase plasminogen activator (scuPA) for treatment of loculated complicated parapneumonic effusions and empyema1U01HL121841-01A1 | IDELL, STEVENMASUR, HENRYWOODS, CHRISTIAN J | UNIVERSITY OF TEXAS HLTH CTR AT TYLER, TX | $74,071 | ZHL1 |
| 2014 | MRI-safe 3Dl intracardiac ultrasound catheter for cardiovascular intervention1U01HL121838-01 · under PAR-13-029 | DEGERTEKIN, F. LEVENTLEDERMAN, ROBERT J | GEORGIA INSTITUTE OF TECHNOLOGY, GA | $683,344 | ZHL1 |
| 2014 | Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML1U01CA183030-01 · under PAR-13-029 | LIU, YANGSCHORE, REUVEN J | CHILDREN'S RESEARCH INSTITUTE, DC | $653,666 | ZCA1 |
| 2014 | Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient1U01CA183012-01 · under PAR-13-029 | ZAIA, JOHN A | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $465,641 | ZCA1 |
| 2014 | Integrative molecular imaging and sequencing of prostate cancer1U01CA183027-01 · under PAR-13-029 | CHINNAIYAN, ARUL MLINEHAN, MARSTON | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $416,880 | ZCA1 |
| 2014 | Birth Defects: Moebius syndrome and related facial weakness disorders1U01HD079068-01 · under PAR-13-029 | BROOKS, BRIAN PATRICKENGLE, ELIZABETH C.JABS, ETHYLIN WANGMANOLI, IRINIPIERPAOLI, CARLO | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $388,120 | ZRG1 |
| 2014 | A Phase 1 Dose Escalation Study of Vorinostat in Niemann-Pick C1 Disease1U01HD079065-01 · under PAR-13-029 | MAXFIELD, FREDERICK R.ORY, DANIEL S | WASHINGTON UNIVERSITY, MO | $360,223 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.